Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Decreased appetite, Headache, Injection site pain, Injection site swelling
Clinical narrative: under same arm (along with tenderness); Booster dose; fever (100.4)/ Low grade fever (100 Degree); chills; nausea; headache; neck pain; Muscle aches; Injection site pain and slight swelling; Injection site pain and slight swelling; pain and swelling under arm; pain and swelling under arm; fatigue; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 51-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 20Oct2021 (Lot number: FF2590) at the age of 51 years as dose 3 (booster), single for covid-19 immunization. The patient's relevant medical history was not reported. Concomitant medication(s) included: SERTRALINE (ongoing); PROGESTERONE; FLULAVAL QUADRIVALENT (Route: L. deltoid), administration left arm, on date 13Oct2021; ZOLOFT (ongoing), Glaxo smith kline (lot number: FP5XD). Vaccination history included: Bnt162b2 (Dose Number: 1, Route of administration: Intramuscular, Batch/Lot number: EK5730), administration date: 24Dec2020, when the patient was 50 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3248), administration date: 13Jan2021, when the patient was 50 years old, for Covid-19 immunization, reaction(s): "Fever", "chills", "fatigue", "muscle aches". The following information was reported: IMMUNISATION (non-serious) with onset 20Oct2021, outcome "unknown", described as "Booster dose"; PYREXIA (non-serious) with onset 20Oct2021, outcome "recovered" (21Oct2021), described as "fever (100.4)/ Low grade fever (100 Degree)"; CHILLS (non-serious) with onset 20Oct2021, outcome "recovered" (21Oct2021), described as "chills"; NAUSEA (non-serious) with onset 20Oct2021, outcome "recovered" (22Oct2021), described as "nausea"; HEADACHE (non-serious) with onset 20Oct2021, outcome "recovered" (21Oct2021), described as "headache"; NECK PAIN (non-serious) with onset 20Oct2021, outcome "recovered" (21Oct2021), described as "neck pain"; MYALGIA (non-serious) with onset 20Oct2021, outcome "recovered" (21Oct2021), described as "Muscle aches"; VACCINATION SITE PAIN (non-serious) with onset 20Oct2021, outcome "recovering", VACCINATION SITE SWELLING (non-serious) with onset 20Oct2021, outcome "recovered" (Oct2021) and all described as "Injection site pain and slight swelling"; PAIN IN EXTREMITY (non-serious) with onset 20Oct2021, outcome "recovering", PERIPHERAL SWELLING (non-serious) with onset 20Oct2021, outcome "recovered" (Oct2021) and all described as "pain and swelling under arm"; FATIGUE (non-serious) with onset 20Oct2021, outcome "recovered" (21Oct2021), described as "fatigue"; TENDERNESS (non-serious) with onset 21Oct2021, outcome "recovered" (Oct2021), described as "under same arm (along with tenderness)". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, chills, nausea, headache, neck pain, myalgia, vaccination site pain, vaccination site swelling, pain in extremity, peripheral swelling.  Additional information: On 20Oct2021, the patient's fever 104 and 100 (Low grade fever (100 degree)).  Follow-up attempts are completed. No further information is expected.